References
- V.AranA.P.VictorinoL.C.ThulerC.G.FerreiraColorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset and mortalityClin Colorectal Cancer2016
- H.-J.KimS.-C.BaeHistone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugsAm J Transl Res32011166179
- A.A.LaneB.A.ChabnerHistone deacetylase inhibitors in cancer therapyJ Clin Oncol27200954595468
- A.C.WestR.W.JohnstoneNew and emerging HDAC inhibitors for cancer treatmentJ Clin Invest12420143039
- K.J.FalkenbergR.W.JohnstoneHistone deacetylases and their inhibitors in cancer, neurological diseases and immune disordersNat Rev Drug Discov132014673691
- S.KaypeeD.SudarshanM.K.ShanmugamD.MukherjeeG.SethiT.K.KunduAberrant lysine acetylation in tumorigenesis: implications in the development of therapeuticsPharmacol Ther2016
- E.BoudadiH.StowerJ.A.HalsallThe histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides polycomb-mediated Hoxb silencingEpigenet Chromatin620131
- R.FujikiA.SatoM.FujitaniT.YamashitaA proapoptotic effect of valproic acid on progenitors of embryonic stem cell-derived glutamatergic neuronsCell Death Dis42013e677
- D.WangY.JingS.OuyangInhibitory effect of valproic acid on bladder cancer in combination with chemotherapeutic agents in vitro and in vivoOncol Lett6201314921498
- J.FengJ.CenJ.LiHistone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of SnailCell Adh Migr92015495501
- P.KumarS.TripathiK.N.PandeyHistone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-A gene interactive roles of modified histones, histone acetyltransferase, p300, and Sp1J Biol Chem289201469917002
- P.KumarR.PeriyasamyS.DasS.NeerukondaI.ManiK.N.PandeyAll-trans retinoic acid and sodium butyrate enhance natriuretic peptide receptor a gene transcription: role of histone modificationMol Pharmacol852014946957
- A.SerafinoP.PierimarchiAtrial natriuretic peptide: a magic bullet for cancer therapy targeting Wnt signaling and cellular pH regulatorsCurr Med Chem2120142401
- J.ZhangZ.ZhaoJ.WangNatriuretic peptide receptor A as a novel target for cancerWorld J Surg Oncol1220141
- X.WangP.RauljiS.S.MohapatraNatriuretic peptide receptor A as a novel target for prostate cancerMol Cancer10201156
- A.A.KasparJ.M.ReichertFuture directions for peptide therapeutics developmentDrug Discov Today182013807817
- J.BelotteN.M.FletcherM.AlexisSox2 gene amplification significantly impacts overall survival in serous epithelial ovarian cancerReprod Sci19337191145420212014
- X.KongX.WangW.XuNatriuretic peptide receptor a as a novel anticancer targetJ Cancer Res682008249256
- M.KuhnMolecular physiology of natriuretic peptide signallingClin Res Cardiol9920047682
- J.ZhangZ.ZhaoC.ZuAtrial natriuretic peptide modulates the proliferation of human gastric cancer cells via KCNQ1 expressionOncol Lett62013407414
- A.GiraultA.PrivéN.T.N.TrinhIdentification of KvLQT1 K+ channels as new regulators of non-small cell lung cancer cell proliferation and migrationInt J Clin Oncol442014838848
- W.ZhanpingP.XiaoyuC.NaW.ShenglanW.BoVoltage-gated K+ channels are associated with cell proliferation and cell cycle of ovarian cancer cellGynecol Oncol1042007455460
- N.FatimaD.C.CohenG.SukumarHistone deacetylase inhibitors modulate KATP subunit transcription in HL-1 cardiomyocytes through effects on cholesterol homeostasisFront Aging Neurosci62015
- A.PapiA.FerreriF.GuerraM.OrlandiAnti-invasive effects and proapoptotic activity induction by the rexinoid IIF and valproic acid in combination on colon cancer cell linesAnticancer Res32201228552862
- C.GuoE.RosohaM.B.LowryN.BorregaardA.F.GombartCurcumin induces human cathelicidin antimicrobial peptide gene expression through a vitamin D receptor-independent pathwayJ Nutr Biochem242013754759
- B.Barneda-ZahoneroM.ParraHistone deacetylases and cancerMol Oncol62012579589
- S.SharmaT.K.KellyP.A.JonesEpigenetics in cancerCarcinogenesis3120102736
- A.Chavez-BlancoC.Perez-PlasenciaE.Perez-CardenasAntineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell linesCancer Cell Int620062
- X.HuangB.GuoAdenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cellsCan Res66200692459251
- X.ChenP.WongE.RadanyJ.Y.WongHDAC inhibitor, valproic acid, induces p53-dependent radiosensitization of colon cancer cellsCancer Biother Radiopharm242009689699
- K.CamphausenD.CernaT.ScottEnhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acidInt J Cancer1142005380386
- E.AbdelalimI.TooyamaNPR-A regulates self-renewal and pluripotency of embryonic stem cellsCell Death Dis22011e127
- A.SerafinoN.MoroniR.PsailaAnti-proliferative effect of atrial natriuretic peptide on colorectal cancer cells: evidence for an Akt-mediated cross-talk between NHE-1 activity and Wnt/β-catenin signalingBiochem Biophys Acta1822201210041018